Activation of peroxisome proliferator-activated receptor γ (PPARγ) through NF-κB/brg1 and TGF-β 1 pathways attenuates cardiac remodeling in pressure-overloaded rat hearts

Cellular Physiology and Biochemistry

Volumn 35, Issue 3, 2015, Pages 899-912

  Qi, Han Ping ^a   Wang, Ye ^a   Zhang, Qian Hui ^a   Guo, Jing ^a   Li, Lei ^a   Cao, Yong Gang ^a   Li, Shu Zhi ^a   Li, Xiao Lei ^a   Shi, Mu Mu ^a   Xu, Wang ^b   Li, Bai Yan ^a   Sun, Hong Li ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b The First Hospital of Qiqihar   (China)

Author keywords

Brg1; Cardiac remodeling; NF B; Peroxisome proliferator activated receptor ; TGF 1

Indexed keywords

ANGIOTENSIN II; BRG1 PROTEIN; BROXURIDINE; COLLAGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1; DNA HELICASE; NUCLEAR PROTEIN; SMARCA4 PROTEIN, RAT; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATPASE ACTIVITY ASSAY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; EXPERIMENTAL MODEL; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSFECTION; HEART HEMODYNAMICS; HEART INFARCTION; HEART LEFT VENTRICLE OVERLOAD; HEART VENTRICLE HYPERTROPHY; IN VITRO STUDY; NONHUMAN; PEROXISOME; PRIORITY JOURNAL; PROTEIN ISOLATION; RAT; WESTERN BLOTTING; ANIMAL; AORTA; BIOSYNTHESIS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; HUMAN; METABOLISM; PATHOLOGY; PRESSURE;

RATTUS;

ANGIOTENSIN II; ANIMALS; AORTA; DNA HELICASES; GENE EXPRESSION REGULATION; HUMANS; MYOCYTES, CARDIAC; NF-KAPPA B; NUCLEAR PROTEINS; PPAR GAMMA; PRESSURE; RATS; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA; VENTRICULAR REMODELING;

EID: 84921898096     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000369747     Document Type: Article

References (38)

1. Cohn JN: Structural changes in eardiovascul disease. Am J Cardiol 1995;76:34E-37E.
2. Bishop-Bailey D, Hla T, Warner TD: Bisphenol A diglycidyl ether (BADGE) is a PPAR gamma agonist in an ECV304 cell line. Br J Pharmacol 2000;131:651-654.
3. Buchanan GR, Rogers ZR: Conservative versus aggressive transfusion regimens in sickle cell disease. N Engl J Med 1995;333:1641-1642.
4. Sidhu JS, Kaski JC: Peroxisome proliferator activated receptor gamma: a potential therapeutic target in the management of ischaemic heart disease. Heart 2001;86:255-258.
5. Chawla A, Boisvert WA, Lee CH, Laffitte BA, Barak Y, Joseph SB, Liao D, Nagy L, Edwards PA, Curtiss LK: A PPAR gamma-LXR-ABCAl pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol Cell 2001;7:161-171.
6. Wilson-Fritch L, Nicoloro S, Chouinard M, Lazar MA, Chui PC, Leszyk J, Straubhaar J, Czech MP, Corvera S: Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone.] Clin Invest 2004;114:1281-1289.
7. Sevini G, Bochaton Piallat ML, Ropraz P, Geinoz A, Borsi L, Zardi L, Gabbiani G: The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-betal. J Cell Biol 1998;142:873-881.
8. Kapur NK: Transforming growth factor-p: governing the transition from inflammation to fibrosis in heart failure with preserved left ventricular function. Circ Heart Fail 2011;4:5-7.
9. Van Setten GB, Blalock TD, Grotendorst G, Schultz GS: Detection of connective tissue growth factor in human aqueous humor. Ophthalmic Res 2002;34:306-308.
10. Polyakova V, Loeffler I, He in S, Miyagawa S, Piotrowska I, Dammer S, Risteli J, Schaper J, Kostin S: Fibrosis in endstage human heart failure: severe changes in collagen metabolism and MMP/TIMP profiles. Int J Cardiol 2011;151:18-33.
11. Martens JA, Winston F: Recent advances in understanding chromatin remodeling by Swi/Snf complexes. Curr Opin Genet Dev 2003;13:136-142.
12. Dunaief JL, Strober BE, Guha S, Khavari PA, Alin K, Luban J, Begemann M, Crabtree GR, Goff SP: The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell 1994;79: 119-130.
13. Xue Y, Wong J, Moreno GT, Young MK, Cote J, Wang W: NURD, a novel complex with both ATP-dependent chromatin-remodelingand histone deacetylase activities. Mol Cell 1998;2:851-861.
14. Hang CT, Yang J, Han P, Cheng HL, Shang C, Ashley E, Zhou B, Chang CP: Chromatin regulation by Brgl underlies heart muscle development and disease. Nature 2010;466:62-67.
15. Lee D, Kim JW, Seo T, Hwang SG, Choi EJ, Choe J: SWI/SNF complex interacts with tumor suppressor p53 and is necessary for the activation of p53-mediated transcription. J Biol Chem 2002; 277: 22330-22337.
16. Bochar DA, Wang L, Beniya H, Kinev A, Xue Y, Lane WS, Wang W, Kashanchi F, Shiekhattar R: BRCA1 is associated with a human SWI/SNF Related complex: linking chromatin remodeling to breast cancer. Cell 2000;102:257-265.
17. Marignani PA, Kanai F, Carpenter CL: LKB 1 associates with Brgl and is necessary for Brgl-induced growth arrest. J Biol Chem 2001;276:32415-32418.
18. Hang CT, Yang J, Han P, Cheng HL, Shang C, Ashley E, Zhou B, Chang CP: Chromatin regulation by Brgl underlies heart muscle development and disease. Nature 2010;466:62-67.
19. Chawla A, Boisvert WA, Lee CH, Laffitte BA, Barak Y, Joseph SB, Liao D, Nagy L, Edwards PA, Curtiss LK, Evans RM, Tontonoz P: A PPAR gamma-LXR-ABCAl pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol Cell 2001;7:161-167.
20. Wurster AL, Precht P, Pazin MJ: NF-icB and BRG1 bind a distal regulatory element in the IL-3/GM-CSF locus. Mol Immunol 2011;48:2178-2188.
21. Perez JR, Higgins-Sochaski KA, Maltese JY, Narayanan R: Regulation of adhesion and growth of fibrosarcoma cells by NF-kappa B RelA involves transforming growth factor beta. Mol Cell Biol 1994;14:5326-5332.
22. Jouannot P, Crozatier B, Hatt PY: Anomalous ventricular contractile performance in experimental chronic aortic insufficiency in the dog. Arch Mai Coeur Vaiss 1976;69:809-817.
23. Kudo A: A method for calculating the inbreeding coefficient. Am J Hum Genet 1962;14:426-432.
24. Yang B, Lin H, Xiao J, Lu Y, Luo X, Li B: Themuscle-specific microRNA miR-1 regulates cardiac arrhythmoge-nic potential by targeting GJA1 and KCNJ2. Nat Med 2007;13:486-491.
25. Douglas PS, Katz SE, Weinberg EO, Chen MH, Bishop SP, Lorell BH: Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload. JACC 1998;32:1118-1125.
26. McMullen JR Sherwood MC, Tarnavski O, Zhang L, Dorfman AL, Shioi T, Izumo S: Inhibition of mTOR signa-ling with rapamycin regresses established cardiac hypertrophy induced by pressure overload. Circulation 2004;109:3050-3055.
27. Nakamura Yl, Ohya Y, Onaka U, Fujii K, Abe I, Fujishima M: Inhibitory action of insulin-sensitizing agents on calcium channels in smooth muscle cells from resistance arteries of guinea-pig. Br J Pharmacol 1998; 123:675-682.
28. Bultman SJ, Gebuhr TC, Magnuson T: A Brgl mutation that uncouples ATPase activity from chromatin remodeling reveals an essential role for SWI/SNF-related complexes in beta-globin expression and erythroid development. Genes Dev 2005;19:2849-2861.
29. Boluyt MO, ONeill L, Meredith AL, Bing OH, Brooks WW, Conrad CH, Crow MT, Lakatta EG: Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure. Marked up regulati-on of genes encoding extracellular matrix components. Circ Res 1994;75:23-32.
30. Heling I, Slutzky-Goldberg I, Lustmann J, Ehrlich Y, Becker A: Bone-like tissue growth in the root canal of immature permanent teeth after traumatic injuries. Endod Dent Traumatol 2000;16:298-303.
31. Murakami A, Koshimizu K, Ohigashi H, Kuwahara S, Kuki W, Takahashi Y, Hosotani K, Kawahara S, Matsuoka Y: Characteristic rat tissue accumulation of nobiletin, a chemopreventive polymethoxyflavonoid, in compa-rison with luteolin. Biofactors 2002;16:73-82.
32. Bujak M, Fran Gogiannis NG: The role of TGF-beta signaling in myocardial infarction and cardiac remode-ling. Cardiovasc Res 2007;74:184-195.
33. Gilmore TD: Introduction to NF-icB: players, pathways, perspectives. Oncogene 2006;25:6680-6684.
34. Brasier AR: The NF-icB regulatory network. Cardiovasc Toxicol 2006;6:111-130.
35. Perkins ND: Integrating cell-signalling pathways with NF-icB and IKK function. Nat Rev Mol Cell Bio 2007;8:49-62.
36. Tian B, Brasier AR: Identification of a nuclear factor kappa B-dependentgene network. Recent Prog Horm Res 2003;58:95-130.
37. Zhang Y, Hu L, Cui Y, Qi Z, Huang X, Cai L, Zhang T, Yin Y, Lu Z, Xiang J: Roles of PPARy/NF-icB signaling pa-thway in the pathogenesis of intrahepatic cholestasis of pregnancy. PLoS One 2014;9:e87343.
38. Remels AH, Langen RC, Gosker HR, Russell AP, Spaapen F, Voncken JW, Schrauwen P, Schols AM: PPAR gamma inhibits NF-kappaB-dependent transcriptional activation in skeletal muscle. Am J Physiol Endocrinol Metab 2009;297:E174-E183.